Clinical trial · Observational
iCCaRE Consortium Pilot Project 1: Feasibility of a Point of Prostate Cancer Diagnosis Intervention for Newly Diagnosed Black Men
NCT06535802CI-TRIAL-00122352completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is being done to determine the acceptance and effectiveness of a virtual robot assistant model at a urology clinic.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Carcinoma | Prostate Carcinoma | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (6)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Clinician Interviews | Other | — | UNRESOLVED |
| Focus group | Other | — | UNRESOLVED |
| Follow-up Interview | Other | — | UNRESOLVED |
| Intervention testing | Other | — | UNRESOLVED |
| Survey | Other | — | UNRESOLVED |
| Virtual Health Intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (4)
- label
- Observational cohort I
- description
- Consumer advocates attend a focus group on study.
- interventionNames
- Other: Focus group
- label
- Observational cohort II
- description
- Clinicians complete interviews on study.
- interventionNames
- Other: Clinician Interviews
- label
- Observational cohort III
- description
- CaP survivors test the virtual health intervention, complete a survey, and attend a focus group on study.
- interventionNames
- Other: Focus group
- Other: Intervention testing
- Other: Survey
Eligibility
Eligibility (as posted)
- Sex
- All
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * AIM 1: iCCaRE Consortium consumer advocates * Clinicians who are part of the Translational Research \& Clinical Intervention Services (TRaCIS) * AIM 2 ALPHA TESTING: iCCaRE consumer advocates \[2 Community Advisory Board (CAB) and 1 non-CAB\] * AIM 2 BETA TESTING-PATIENTS: * An African American/Black male * A patient who has been diagnosed with prostate cancer in Florida at any time in their life, and/or within the previous 6 months has had an abnormal Prostate-Specific Antigen (PSA) lab value and/or Digital Rectal Examination (DRE) * Minimum age of 30 years old * Consent to participating in the intervention Exclusion Criteria: * AIM 2 BETA TESTING-PATIENTS: * Patients who are not African American/Black males * Patients not diagnosed with prostate cancer in Florida at any time in their life, or within the previous 6 months has not had a normal PSA lab value and/or DRE * Older than 80 years old * Are not willing to consent
References
Publications (0)
Data not yet available
No reference posted for this study.